Relationship between injury severity and serum tau protein levels in traumatic brain injured rats

Resuscitation

Volumn 81, Issue 9, 2010, Pages 1205-1208

  Liliang, Po Chou ^a   Liang, Cheng Loong ^a   Lu, Kang ^a   Wang, Kuo Wei ^a   Weng, Hui Ching ^a   Hsieh, Ching Hua ^b   Tsai, Yu Duan ^a   Chen, Han Jung ^a  

^a I SHOU UNIVERSITY   (Taiwan)

^b CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

Author keywords

Biomarker; ELISA; Immunoblotting; Tau protein; Traumatic brain injury

Indexed keywords

TAU PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL EVALUATION; CONTROLLED STUDY; CONTUSION; ENZYME LINKED IMMUNOSORBENT ASSAY; HISTOLOGY; IMMUNOBLOTTING; INJURY SEVERITY; MALE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; TRAUMATIC BRAIN INJURY;

ANIMALS; BRAIN INJURIES; ENZYME-LINKED IMMUNOSORBENT ASSAY; IMMUNOBLOTTING; MALE; NERVOUS SYSTEM; PARIETAL LOBE; RATS; RATS, SPRAGUE-DAWLEY; TAU PROTEINS; TIME FACTORS; TRAUMA SEVERITY INDICES;

EID: 77955845217     PISSN: 03009572     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.resuscitation.2010.05.016     Document Type: Article

References (27)

1. Chiu W.T., Huang S.J., Tsai S.H., et al. The impact of time, legislation, and geography on the epidemiology of traumatic brain injury. J Clin Neurosci 2007, 14:930-935.
2. Lin J.W., Tsai S.H., Tsai W.C., et al. Survey of traumatic intracranial hemorrhage in Taiwan. Surg Neurol 2006, 66:S20-S25.
3. Lin J.W., Lin C.M., Tsai J.T., et al. Neurotrauma research in Taiwan. Acta Neurochir Suppl 2008, 101:113-117.
4. Marion D.W. Outcome from severe head injury. Neurotrauma 1996, 767-777. McGraw Hill, New York. R.K. Narayan, E. Wilberger, J.T. Povlishock (Eds.).
5. Woertgen C., Rothoerl R., Metz C., et al. Comparison of clinical, radiologic, and serum marker as prognostic factors after severe head injury. J Trauma 1999, 47:1126-1130.
6. Raabe A., Grolms C., Sorge O., et al. Serum S-100B protein in severe head injury. Neurosurgery 1999, 45:477-483.
7. Korfias S., Stranjalis G., Boviatsis E., et al. Serum S-100B protein monitoring in patients with severe traumatic brain injury. Intensive Care Med 2007, 33:255-260.
8. Vos P.E., Lamers K.J., Hendriks J.C., et al. Glial and neuronal proteins in serum predict outcome after severe traumatic brain injury. Neurology 2004, 62:1303-1310.
9. Ost M., Nylén K., Csajbok L., et al. Initial CSF total tau correlates with 1-year outcome in patients with traumatic brain injury. Neurology 2006, 67:1600-1604.
10. Franz G., Beer R., Kampfl A., et al. Amyloid beta 1-42 and tau in cerebrospinal fluid after severe traumatic brain injury. Neurology 2003, 60:1457-1461.
11. Kavalci C., Pekdemir M., Durukan P., et al. The value of serum tau protein for the diagnosis of intracranial injury in minor head trauma. Am J Emerg Med 2007, 25:391-395.
12. Bulut M., Koksal O., Dogan S., et al. Tau protein as a serum marker of brain damage in mild traumatic brain injury: preliminary results. Adv Ther 2006, 23:12-22.
13. Gabbita S.P., Scheff S.W., Menard R.M., et al. Cleaved-tau: a biomarker of neuronal damage after traumatic brain injury. J Neurotrauma 2005, 22:83-94.
14. Feeney D.M., Boyeson M.G., Linn R.T., et al. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981, 211:67-77.
15. Ringger N.C., O'Steen B.E., Brabham J.G., et al. A novel marker for traumatic brain injury: CSF II-spectrin breakdown product levels. J Neurotrauma 2004, 21:1443-1456.
16. Chen Y., Constantini S., Trembovler V., et al. An experimental model of closed head injury in mice: pathophysiology, histopathology, and cognitive deficits. J Neurotrauma 1996, 3:557-568.
17. Stahel P.F., Shohami E., Younis F.M., et al. Experimental closed head injury: analysis of neurological outcome, blood-brain barrier dysfunction, intracranial neutrophil infiltration, and neuronal cell death in mice deficient in genes for proinflammatory cytokines. J Cereb Blood Flow Metab 2000, 20:369-380.
18. Schunk J.E., Rodgerson J.D., Woodward G.A. The utility of head computed tomographic scanning in pediatric patients with normal neurologic examination in the emergency department. Pediatr Emerg Care 1996, 12:160-165.
19. Shaw G.J., Jauch E.C., Zemlan F.P. Serum cleaved tau protein levels and clinical outcome in adult patients with closed head injury. Ann Emerg Med 2002, 39:254-257.
20. Zemlan F.P., Jauch E.C., Mulchahey J., et al. C-tau biomarker of neuronal damage in severe brain injured patients: association with elevated intracranial pressure and clinical outcome. Brain Res 2002, 947:131-139.
21. Sjögren M., Davidsson P., Tullberg M., et al. Both total and phosphorylated tau are increased in Alzheimer's disease. J Neurol Neurosurg Psychiatry 2001, 70:624-630.
22. Arai H., Terajima M., Miura M., et al. Tau in cerebrospinal fluid: a potential diagnostic marker in Alzheimer's disease. Ann Neurol 1995, 38:649-652.
23. Chatfield D.A., Zemlan F.P., Day D.J., Menon D.K. Discordant temporal patterns of S100beta and cleaved tau protein elevation after head injury: a pilot study. Br J Neurosurg 2002, 16:471-476.
24. Bazarian J.J., Blyth B., Zemlan F., Stigbrand T. S100b and cleaved tau are poor predictors of long-term outcome after mild TBI. Brain Inj 2006, 20:759-765.
25. Liliang P.C., Liang C.L., Weng H.C., et al. tau proteins in serum predict outcome after severe traumatic brain injury. J Surg Res 2010, 160:302-307.
26. Woertgen C., Rothoerl R.D., Brawanski A. Neuron-specific enolase serum levels after controlled cortical impact injury in the rat. J Neurotrauma 2001, 18:569-573.
27. Woertgen C., Rothoerl R.D., Wiesmann M., Missler U., Brawanski A. Glial and neuronal serum markers after controlled cortical impact injury in the rat. Acta Neurochir Suppl 2002, 81:205-207.